§ 13F · FUND PROFILE
BAKER BROS. ADVISORS LP.
Institutional filer · behavioral pattern: Other. Summary pending.
AUM · $13.8B (13F)Positions · 91Turnover · — · Q1Filed · May 15, 2026
CONCENTRATION
—
Top 10 holdings
NEW BUYS
0
+$118M deployed
EXITS
0
No exits
SECTOR SHIFT
—
No prior quarter data
3YR HIT RATE
—
Top-5 overlap
§ 01 · TOP HOLDINGS
The book · Q1 2026
FILED MAY 15, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q1 |
|---|---|---|---|---|---|---|
| 1 | INCY | Incyte Corporation | 30.74M | $2.9B | 16.6% | ±0% |
| 2 | ONC | BeOne Medicines Ltd. | 8.80M | $2.6B | 15.0% | ±0% |
| 3 | INSM | Insmed Incorporated | 7.42M | $1.2B | 7.0% | +13% |
| 4 | MDGL | Madrigal Pharmaceuticals, Inc. | 2.14M | $1.1B | 6.4% | ±0% |
| 5 | ACAD | ACADIA Pharmaceuticals Inc. | 42.90M | $955M | 5.5% | ±0% |
| 6 | RVMD | Revolution Medicines, Inc. | 9.56M | $929M | 5.3% | +1% |
| 7 | CELC | Celcuity Inc. | 7.92M | $904M | 5.2% | ±0% |
| 8 | KOD | Kodiak Sciences Inc. | 19.92M | $759M | 4.4% | ±0% |
| 9 | KYMR | Kymera Therapeutics, Inc. | 8.66M | $721M | 4.1% | ±0% |
| 10 | SMMT | Summit Therapeutics Inc. | 36.39M | $690M | 4.0% | ±0% |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE BAKER SIGNAL
AC read
BAKER BROS. ADVISORS LP is a Other fund managing $13.8 billion in assets. The fund runs a portfolio of 91 positions.
Read the full dossier →§ 04 · FILING HISTORY
Q-by-Q deltas
2 FILINGS
Q1 2026
Steady book
+0 buys · −0 exits · 0 changed
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed
Q3 2025
Steady book
+0 buys · −0 exits · 0 changed
Q1 2025
Steady book
+0 buys · −0 exits · 0 changed